|
CN104086527A
|
|
Synthetic method of alogliptin benzoate
|
|
CN103664845A
|
|
Preparation method of Plk (Polo-like kinase) inhibitor drug intermediate 7-amino-2,3-dihydrobenzofuran-4-formic acid
|
|
CN103570696A
|
|
Method for preparing intermediate of axitinib and application of intermediate in preparation of axitinib
|
|
CN103288906A
|
|
A 3,5 - bis-O-benzoyl-2-C-methyl-C-methyl C-4 - (1,2,4 - triazolyl) uridine and a synthesis method thereof
|
|
CN103304492A
|
|
Synthesis method of EGFR (epidermal growth factor receptor) inhibitor Dacomitinib
|
|
CN103274986A
|
|
Method for synthetising and refining sunitinib intermediate
|
|
CN103073504A
|
|
Synthetic method of 5-substituted thiophenyl-benziminazole-2-N-methoxycarbonylamino compound
|
|
CN102827156A
|
|
Novel industrial synthetic method of dasatinib
|
|
CN102827144A
|
|
Preparation method of imatinib
|
|
CN102617481A
|
|
Preparation method of rosuvastatin calcium
|
|
CN103304434A
|
|
Novel synthesizing method of dapoxetine
|
|
CN103304550A
|
|
Preparation method of Olmesartan Medoxomil
|
|
CN102617440A
|
|
Method for preparing atorvastatin calcium
|
|
CN102351860A
|
|
Synthesis method of panipenem and intermediates thereof
|
|
CN102351861A
|
|
Industrial preparation method of ertapenem
|
|
CN102250013A
|
|
Preparation method of albendazole
|
|
CN102304090A
|
|
Method for preparing 5-substituted thiophenyl-benzimidazol-2-N-methoxycarbonyl compound
|
|
CN102174047A
|
|
Novel process for preparing doripenem
|
|
CN102153601A
|
|
Method for preparing gemcitabine hydrochloride and intermediate thereof with high selectivity
|
|
CN102140124A
|
|
Novel synthesis process of capecitabine
|
